Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

The panelist discusses how recurrent Clostridioides difficile infections involve complex differential diagnosis, including persistent infection, reinfection, and other gastrointestinal conditions.

The incidence of Clostridium difficile infection is increasing, according to a study presented by Mayo Clinic researchers during Digestive Disease Week 2012. Researchers found the incidence of C.

Scientists at The Scripps Research Institute (TSRI) have discovered a potential new weapon against Clostridium difficile, a bacterium that causes hundreds of thousands of severe intestinal infections ...

A recent Centers for Disease Control and Prevention report found 75 percent of patients in a group of 10,342 cases were already colonized with C. difficile at the time of hospital admission, according ...

Researchers from the University of Michigan in Ann Arbor and North CarolinaStateUniversity at Raleigh found primary bile acids in the small intestine allowed harmful bacteria to grow regardless of ...

At the end of 2010, Ellis Hospital noticed a troubling spike in Clostridium difficile infections. Clostridium difficile, or C-diff, is a common cause of diarrhea acquired in healthcare settings; it ...

Clostridioides difficile, a Gram-positive, anaerobic, spore-forming bacillus, has emerged as a predominant pathogen, causing antimicrobial-associated ...

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive global license agreement with Valneva SE (Nasdaq: ...

The Food and Drug Administration has approved a fecal microbiota pill to treat recurrent infections caused by Clostridium difficile (C. diff), an antibiotic-resistant bacterium deemed an urgent threat ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study found a 45% reduction in C. diff infections among high-risk patients when the antibiotic doxycycline was used instead ...